Leading German healthcare provider
GHD (“the Company”) is a market leader for healthcare services in Germany, providing medical devices to patients at home. GHD operates an integrated business model including production of ostomy bags and pharmaceuticals to the oncology market as well as wholesale/logistics services.
GHD was founded in 1992 and since then has built a national presence, employing over 800 trained medical experts among other staff at the time of exiting. The Company is headquartered in Ahrensburg, Germany.
GHD was acquired through the IK 2007 Fund in September 2010, and subsequently sold to Nordic Capital in August 2014.
Our Value Creation Strategy
During our ownership, we worked alongside the management team to:
- Facilitate organic growth via leveraging strong market position;
- Increased penetration of existing segments and via add-on acquisitions; and
- Introduce focus on operational excellence.
Quote from the Client
“The past four years have seen a period of tremendous growth for the business, moving from a market leader in homecare to a fully integrated provider of care for patients from diagnosis through every step of their treatment. We have worked very well with our shareholder IK and thank them for their support. Looking ahead, we are pleased to be entering into a partnership with Nordic Capital to support the Company’s future strategic development. We have exciting opportunities to grow further through the expansion of our business, increased production capacity and in providing newly developed therapies to patients, as well as through value-accretive acquisitions. I would like to thank our management and employees for all their hard work in helping us get where we are today.”
Andreas Rudolph, Chief Executive Officer and Founder, GHD